News from us and our partners

Tags

Topics

0 results

News
19 September, 2017
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
News
19 September, 2017
ProQR receives Orphan Drug Designation from FDA
News
12 September, 2017
Sofinnova Partners announces DNA Script’ successful Series A fundraising of €11 M
News
15 June, 2017
ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology
News
8 June, 2017
Avantium N.V. proudly announces that a BBI subsidy of EUR 25 million has been granted to the Industry Consortium “PEFerence”. The consortium, consisting of 11 companies including Synvina, Avantium, BA
News
8 June, 2017
ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial
News
31 May, 2017
ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10
News
22 May, 2017
Graziano Seghezzi est promu Managing Partner de Sofinnova Partners
News
22 May, 2017
Graziano Seghezzi appointed Managing Partner of Sofinnova Partners
News
17 May, 2017
ProQR Announces Results for the First Quarter of 2017
News
17 May, 2017
NOXXON PHARMA ANNOUNCES COLLABORATION WITH NATIONAL CENTER FOR TUMOR DISEASES IN HEIDELBERG FOR NOX-A12/KEYTRUDA® PHASE 1/2 COMBINATION TRIAL
News
12 May, 2017
Shockwave Medical Appoints Doug Godshall as President and CEO
News
9 May, 2017
Mainstay Medical Starts Commercialization of ReActiv8® for the Treatment of Chronic Low Back Pain in Ireland
News
9 May, 2017
RefleXion Medical appoints Todd Powell as president and CEO
News
5 May, 2017
Hookipa Biotech presents positive data from Phase 1 first-in-human trial of vaccine against cytomegalovirus
News
11 April, 2017
Mission Therapeutics and University of Oxford Awarded Research Grant from the Michael J. Fox Foundation

Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

ProQR receives Orphan Drug Designation from FDA

Sofinnova Partners announces DNA Script’ successful Series A fundraising of €11 M

ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology

Avantium N.V. proudly announces that a BBI subsidy of EUR 25 million has been granted to the Industry Consortium “PEFerence”. The consortium, consisting of 11 companies including Synvina, Avantium, BA

ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial

ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10

Graziano Seghezzi est promu Managing Partner de Sofinnova Partners

Graziano Seghezzi appointed Managing Partner of Sofinnova Partners

ProQR Announces Results for the First Quarter of 2017

NOXXON PHARMA ANNOUNCES COLLABORATION WITH NATIONAL CENTER FOR TUMOR DISEASES IN HEIDELBERG FOR NOX-A12/KEYTRUDA® PHASE 1/2 COMBINATION TRIAL

Shockwave Medical Appoints Doug Godshall as President and CEO

Mainstay Medical Starts Commercialization of ReActiv8® for the Treatment of Chronic Low Back Pain in Ireland

RefleXion Medical appoints Todd Powell as president and CEO

Hookipa Biotech presents positive data from Phase 1 first-in-human trial of vaccine against cytomegalovirus

Mission Therapeutics and University of Oxford Awarded Research Grant from the Michael J. Fox Foundation